Publication | Closed Access

Vaccination with IL-12 gene-modified autologous melanoma cells: preclinical results and a first clinical phase I study

VaccinationTumor ImmunologyCancer ImmunosurveillanceMelanomaImmunologyTherapeutic VaccinePreclinical ResultsImmunomodulationDermatologyFirst Clinical PhaseImmunotherapyMedicine